Document is current
Any future updates will be listed below
-
Authors
Uchimoto, Taizo
Iwatsuki, Kengo
Komura, Kazumasa https://orcid.org/0000-0003-4157-1929
Fukuokaya, Wataru
Adachi, Takahiro
Hirasawa, Yosuke
Hashimoto, Takeshi
Yoshizawa, Atsuhiko
Saruta, Masanobu
Hashimoto, Mamoru
Minami, Takafumi
Yamamoto, Yutaka
Yamazaki, Shogo
Takai, Tomoaki
Sakamoto, Moritoshi
Nakajima, Yuki
Nishimura, Kazuki
Maenosono, Ryoichi
Tsujino, Takuya
Nakamura, Ko
Fukushima, Tatsuo
Nishio, Kyosuke
Yoshikawa, Yuki
Yamamoto, Shutaro
Iwatani, Kosuke
Urabe, Fumihiko
Mori, Keiichiro
Yanagisawa, Takafumi
Tsuduki, Shunsuke
Takahara, Kiyoshi
Fujita, Kazutoshi
Kimura, Takahiro
Ohno, Yoshio
Shiroki, Ryoichi
Azuma, Haruhito
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (21H03070)
Kenzo Suzuki Memorial Foundation
SGH Foundation
Naito Memorial Foundation
Cancer Translational Research Foundation of Japanese Urological Association
- License Information
-
More Information
Article History
Received: 10 November 2024
Accepted: 18 January 2025
First Online: 31 January 2025
Declarations
:
: Komura K has received honoraria from Astellas. Fujita K has received honoraria from Bristol Myers Squibb, Merck Sharp & Dohme (MSD), AstraZeneca, Takeda, Astellas, Janssen, Ono, and Ferring Pharmaceutical Co., Ltd. Kimura K has received honoraria from Astellas, AstraZeneca, Bayer, Janssen, Sanofi and Takeda Pharmaceutical Co., Ltd.
: This study was approved by the Institutional Review Board (IRB) from Osaka Medical and Pharmaceutical University (approval number: RIN-750-2571, approved on 24th January 2020).
